07.21.11
Robinson Pharma Inc. (RPI) has introduced an Omega 3 Fish Oil product line exclusively encapsulated with patent-pending ARTcaps technology. Available in 1400 mg, 1200 mg and 1000 mg, the products assure enteric release. Customers can select from a range of three capsule weights, clear or colored ARTcaps gelatin, and a range of potencies and concentrations for the active omega 3 fish oil fill materials. Of specific interest is ARTcaps suitability to free fatty acid (FFA) forms of omega 3. The FFA form of fish oil is of specific importance to consumers with elevated cholesterol and blood sugar as more common ethyl ester (EE) and triglyceride (TG) fish oil forms can impact blood glucose and cholesterol levels in these individuals, according to the company. ARTcaps products offer acid and rupture resistance and use Generally Recognized As Safe ingredients. For further information: www.robinsonpharma.com
